IT1144812B - Composizione antibatterica liofilizzata a base di beta lattami protetta contro la formazione di colore e procedimento per la sua preparazione - Google Patents

Composizione antibatterica liofilizzata a base di beta lattami protetta contro la formazione di colore e procedimento per la sua preparazione

Info

Publication number
IT1144812B
IT1144812B IT67863/81A IT6786381A IT1144812B IT 1144812 B IT1144812 B IT 1144812B IT 67863/81 A IT67863/81 A IT 67863/81A IT 6786381 A IT6786381 A IT 6786381A IT 1144812 B IT1144812 B IT 1144812B
Authority
IT
Italy
Prior art keywords
lattami
lyophylized
beta
procedure
preparation
Prior art date
Application number
IT67863/81A
Other languages
English (en)
Other versions
IT8167863A0 (it
Inventor
Eizo Hirai
Kazuhiro Shima
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of IT8167863A0 publication Critical patent/IT8167863A0/it
Application granted granted Critical
Publication of IT1144812B publication Critical patent/IT1144812B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
IT67863/81A 1980-06-23 1981-06-22 Composizione antibatterica liofilizzata a base di beta lattami protetta contro la formazione di colore e procedimento per la sua preparazione IT1144812B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8578980A JPS5711909A (en) 1980-06-23 1980-06-23 Stable freeze-dried preparation of beta-lactam

Publications (2)

Publication Number Publication Date
IT8167863A0 IT8167863A0 (it) 1981-06-22
IT1144812B true IT1144812B (it) 1986-10-29

Family

ID=13868648

Family Applications (1)

Application Number Title Priority Date Filing Date
IT67863/81A IT1144812B (it) 1980-06-23 1981-06-22 Composizione antibatterica liofilizzata a base di beta lattami protetta contro la formazione di colore e procedimento per la sua preparazione

Country Status (31)

Country Link
US (1) US4418058A (it)
JP (1) JPS5711909A (it)
KR (1) KR840000693B1 (it)
AR (1) AR230007A1 (it)
AT (1) AT380790B (it)
AU (1) AU541627B2 (it)
BE (1) BE889351A (it)
BG (1) BG37991A3 (it)
CA (1) CA1164801A (it)
CH (1) CH648210A5 (it)
CS (1) CS221835B2 (it)
DD (1) DD159879A5 (it)
DE (1) DE3124592A1 (it)
DK (1) DK158443C (it)
ES (1) ES503283A0 (it)
FI (1) FI75490C (it)
FR (1) FR2484835A1 (it)
GB (1) GB2078737B (it)
GR (1) GR75646B (it)
HU (1) HU183494B (it)
IE (1) IE51331B1 (it)
IL (1) IL63136A (it)
IT (1) IT1144812B (it)
NL (1) NL191777C (it)
NO (1) NO156036C (it)
NZ (1) NZ197414A (it)
PT (1) PT73239B (it)
RO (1) RO82720B (it)
SE (1) SE460702B (it)
YU (1) YU44416B (it)
ZA (1) ZA814203B (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597193A (ja) * 1982-07-02 1984-01-14 Shionogi & Co Ltd マロニルメチル基の異性化方法
JPS6045514A (ja) * 1983-08-22 1985-03-12 Shionogi & Co Ltd 安定な抗菌性凍結乾燥製剤
US4797388A (en) * 1984-05-21 1989-01-10 Cetus Corporation Pharmaceutical compositions with galactitol as carrier
US4891391A (en) * 1985-01-03 1990-01-02 Morton Thiokol, Inc. Compositions containing antimicrobial agents in combination with stabilizers
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
DE3801179A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten
CN1556712A (zh) * 2000-07-13 2004-12-22 ��һ��������ҩ��ʽ���� 含dds化合物的药用组合物
US7378408B2 (en) * 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
CN105392485B (zh) 2013-03-15 2019-08-02 默沙东公司 头孢特咯瓒抗生素组合物
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS532931B2 (it) * 1973-12-05 1978-02-01
US3928592A (en) * 1974-02-22 1975-12-23 Lilly Co Eli Antibiotic pharmaceutical compositions
US3993753A (en) * 1974-08-26 1976-11-23 American Home Products Corporation Anhydrous ampicillin stabilization and resultant compositions
GB1463563A (en) * 1974-10-10 1977-02-02 Beecham Group Ltd Pharmaceutical compositions
JPS5151511A (en) * 1974-10-25 1976-05-07 Tooru Tatsuhara Aminosanseizai no anteikaho
US4180571A (en) * 1976-03-25 1979-12-25 Shionogi & Co., Ltd. Arylmalonamido-1-oxadethiacephalosporins
JPS532931A (en) * 1976-06-30 1978-01-12 Saraya Kk Toilet bowl cleaning method
SE7714312L (sv) * 1976-12-17 1978-06-18 Scherico Ltd Antibiotiska kompositioner
JPS53104722A (en) * 1977-02-19 1978-09-12 Tsumura Juntendo Kk Production of powder for making herb medicine liquid agent
CA1127450A (en) * 1978-08-26 1982-07-13 Gordon L. Mcglennon Load multiplying mechanisms
US4259485A (en) * 1979-04-24 1981-03-31 Eli Lilly And Company Crystallization process

Also Published As

Publication number Publication date
ZA814203B (en) 1982-09-29
IE811347L (en) 1981-12-23
PT73239B (en) 1982-07-22
IE51331B1 (en) 1986-12-10
KR830005848A (ko) 1983-09-14
KR840000693B1 (ko) 1984-05-21
DK158443B (da) 1990-05-21
ES8203887A1 (es) 1982-04-01
SE460702B (sv) 1989-11-13
JPS6364405B2 (it) 1988-12-12
DE3124592C2 (it) 1990-12-20
NL8102943A (nl) 1982-01-18
NZ197414A (en) 1984-10-19
AR230007A1 (es) 1984-02-29
FI811948L (fi) 1981-12-24
GB2078737A (en) 1982-01-13
BE889351A (fr) 1981-10-16
ES503283A0 (es) 1982-04-01
CS221835B2 (en) 1983-04-29
JPS5711909A (en) 1982-01-21
DE3124592A1 (de) 1982-02-11
DK274981A (da) 1981-12-24
IL63136A0 (en) 1981-09-13
DD159879A5 (de) 1983-04-13
AU7209781A (en) 1983-01-06
CH648210A5 (de) 1985-03-15
NL191777B (nl) 1996-04-01
IT8167863A0 (it) 1981-06-22
CA1164801A (en) 1984-04-03
GB2078737B (en) 1984-03-14
BG37991A3 (en) 1985-09-16
US4418058A (en) 1983-11-29
SE8103904L (sv) 1981-12-24
FR2484835A1 (fr) 1981-12-24
RO82720A (ro) 1984-05-23
NO156036C (no) 1987-07-15
NO812090L (no) 1981-12-28
YU157381A (en) 1984-10-31
FR2484835B1 (it) 1983-07-01
HU183494B (en) 1984-05-28
YU44416B (en) 1990-08-31
NL191777C (nl) 1996-08-02
PT73239A (en) 1981-07-01
RO82720B (ro) 1984-07-30
FI75490C (fi) 1988-07-11
GR75646B (it) 1984-08-02
FI75490B (fi) 1988-03-31
AT380790B (de) 1986-07-10
IL63136A (en) 1984-07-31
DK158443C (da) 1990-10-08
NO156036B (no) 1987-04-06
AU541627B2 (en) 1985-01-17
ATA278881A (de) 1985-12-15

Similar Documents

Publication Publication Date Title
LV5376A3 (lv) Smekejamais izstradajums
AU549757B2 (en) Visually clear coloured dentifrice
IT1144812B (it) Composizione antibatterica liofilizzata a base di beta lattami protetta contro la formazione di colore e procedimento per la sua preparazione
IT1212411B (it) Antibiotico a/16686 e procedimento per la sua preparazione.
AT381878B (de) Stranggiesskokille
DK548285D0 (da) Belaegningssammensaetning
DK80785A (da) Bageform
AU548337B2 (en) Dentifrice composition
PH18581A (en) Dentifrice composition
JPS57119998A (en) Shampoo composition
AT374386B (de) Stranggiesskokille
BR8206703A (pt) Composicoes pesticidas e processo de preparacao
IT1119917B (it) Composto antibatterico e procedimento per la sua preparazione
GB2099701B (en) Insect pesticidal composition
IT1197433B (it) Composizioni antibatteriche e anticoccidiche e procedimento per la loro preparazione
AU4616485A (en) Gate catch
GB8529182D0 (en) Antibacterial preparations
IT1133647B (it) Composto ad attivita' antibatterica e procedimento per la sua preparazione
IT1141052B (it) Composto ad attivita' antibatterica e procedimento per la sua preparazione
IT8435882V0 (it) Self-service croissants
IT1182223B (it) Formulazione fungicida
IL84057A0 (en) Novel organic compounds and their preparation
KR860006066U (ko) 과자용기
BR8102700A (pt) Codificador hdb 3/ami
ATE50691T1 (de) Stabilisiertes muschelpraeparat.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950630